Skip to main content
. 2010 Mar;332(3):1072–1080. doi: 10.1124/jpet.109.158113

TABLE 1.

Animal data at 50 weeks of age

LETO + Vehicle OLETF + Vehicle OLETF + Telmisartan OLETF + Eplerenone OLETF + Telmisartan + Eplerenone OLETF + Hydralazine
No. 10 12 12 12 12 12
BW (g) 500 ± 15 629 ± 25* 602 ± 28* 608 ± 23* 611 ± 21* 605 ± 29*
Right KW (g) 1.31 ± 0.03 2.45 ± 0.13* 1.92 ± 0.11* 1.96 ± 0.15* 1.86 ± 0.09* 2.28 ± 0.21*
Right KW/BW ratio (%) 0.27 ± 0.02 0.38 ± 0.04* 0.32 ± 0.03* 0.32 ± 0.04* 0.29 ± 0.04 0.35 ± 0.06*
PPBG (mg/dl) 6 ± 2 14 ± 3* 13 ± 2* 13 ± 4* 13 ± 3* 14 ± 4*
Plasma sodium (mEq/l) 144 ± 5 145 ± 8 143 ± 6 142 ± 5 141 ± 6 144 ± 8
Plasma potassium (mEq/l) 4.2 ± 0.3 4.4 ± 0.3 4.8 ± 0.5 4.9 ± 0.4 4.9 ± 0.6 4.8 ± 0.6
Plasma Cr (mg/dl) 0.39 ± 0.03 0.41 ± 0.05 0.41 ± 0.04 0.40 ± 0.03 0.39 ± 0.05 0.43 ± 0.06
Plasma aldosterone (pg/ml) 281 ± 44 368 ± 61 216 ± 49 873 ± 102* 726 ± 74* 383 ± 48

BW, body weight; KW, kidney weight.

*

P < 0.05 vs. LETO + vehicle.

P < 0.05; OLETF + vehicle vs. OLETF + telmisartan, eplerenone, or telmisartan + eplerenone.